Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (02): 54-59    DOI:
    
Preparation and Preliminary Application of Human Protein DFF45 Polyclonal Antibody
Tianjin Life Science Research Center Basic Medical School of Tianjin Medical University, Tianjin 300070, China
Download: HTML   PDF(639KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

To express and purify the fusion protein of GST-tagged DNA fragmentation factor 45(DFF45) in prokaryocytes and prepare anti-DFF45 polyclonal antibody. The expression plasmid pGEX-5X-1/DFF45 was constructed and transformed into E.coli BL21, and the expression of GST-DFF45 protein was induced by IPTG. After purification, the fusion protein GST-DFF45 was used to immunize Oryctolagus cuniculus to obtain the antibody serum. Then the anti-DFF45 serum was purified by CNBr-activated Sepharose? 4B. The titer of the polyclonal antibody was detected by ELISA and its specificity was analyzed by Western blotting and immunofluorescence. Furthermore, we detected the expression of DFF45 protein in several human cell lines, and observed the cellular localization of DFF45 protein. The fusion protein was successfully expressed and purified, and the specific polyclonal antibody was prepared. The titer of the polyclonal antibody was up to 1:20 000 detected by ELISA, and the high specificity of the antibody was confirmed by Western blotting and immunofluorescence. Moreover, we found that DFF45 protein showed differential expression in several human cell lines. We also found that DFF45 protein was located in both cytoplasm and nucleus. The successful preparation of DFF45 polyclonal antibody and the confirmation of its different expression levels in human cells provides a tool for the further study of the relation between DFF45 and tumors.



Key wordsDFF45      Fusion protein      Polyclonal antibody     
Received: 26 November 2009      Published: 26 February 2010
Cite this article:

KONG Wei-Jing, LI Hai-Fang, LIU Chao, TUN Hai-Dong, JIANG Dan, SHANG Dan-Meng, LIU Min, SHANG Hua. Preparation and Preliminary Application of Human Protein DFF45 Polyclonal Antibody. China Biotechnology, 2010, 30(02): 54-59.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I02/54

[1] 凌诒萍.细胞生物学.北京:人民卫生出版社,2001.234242. Ling Y P. Cell Biology. Beijing: People’s Medical Publishing House,2001.234242. 
[2] Enari M , Sokahira H, Yokoyama H, et al. A caspaseactivated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature,1998,391(6662): 4350. 
[3] McCarty J S, Toh S Y, Li P. Multiple domains of DFF45 bind synergistically to DFF40: roles of caspase cleavage and sequestration of activator domain of DFF40. Biochem Biophys Res Commun,1999,264(1):181185. 
[4] 梁素美,陈洪雷,柯尊富,等. Caspase3及其底物 DFF45在人肺癌组织中的表达及意义.中国肿瘤临床,2005,32(12):666669. Liang S M, Chen H L, Ke Z F, et al. Chinese Journal of Clinical Oncology, 2005,32(12):666669. 
[5] 余映,田慧军. Caspase3及其底物DFF45在大肠腺癌组织中的表达和意义.现代肿瘤医学,2008,16(4):609611. Yu Y, Tian H J. Modern Oncology, 2008,16(4):609611. 
[6] Depraetere V, Golstein P. Dismantling in cell death:molecular mechanisms and relationship to caspase activation. Scand J Immunol,1998,47(6):523531. 
[7] Boulares A H, Zoltoski A J, Yakovlev A, et a1. Roles of DNA fragmentation factor and poly(ADPribose) polymerase in an amplification phase of tumor necrosis factorinduced apoptosis. J Biol Chem,2001,276(41):38185 38192. 
[8] Zhou P, Lugovskoy A A, McCarty J S, et al. Solution structure of DFF40 and DFF45 Nterminal domain complex and mutual chaperone activity of DFF40 and DFF45. Proc Natl Acad Sci U S A,2001,98(11):60516055. 
[9] Charrier L, Jarry A, Toquet C, et al. Growth phasedependent expression of ICADL/DFF45 modulates the pattern of apoptosis in human colonic cancer cells. Cancer Res,2002,62(7):21692174. 
[10] Rajandram R, Pat B K, Li J, et al. Expression of apoptotic tumour necrosis factor receptorassociated factor, caspase recruitment domain and cell deathinducing DFF45 effector genes in therapytreated renal cell carcinoma. Nephrology,2009,14(2):205212. 
[11] Ejeskr K, Fransson S, Zaibak F, et al. Method for efficient transfection of in vitrotranscribed mRNA into SKNAS and HEK293 cells: difference in the toxicity of nuclear EGF Pcompared to cytoplasmic EGFP. Int J Mol Med,2006,17(6):10111016.

[1] CHEN Xiu-yue,ZHOU Wen-feng,HE Qing,SU Bing,ZOU Ya-wen. Preparation, Purification and Identification of Bacteriophage Qβ Virus-like Particles[J]. China Biotechnology, 2021, 41(7): 42-49.
[2] CHEN Qiu-li,YANG Li-chao,LI Hui,WEN Sha,LI Gang,HE Min. Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein[J]. China Biotechnology, 2020, 40(3): 31-37.
[3] Ying CHEN,Hai-peng XIAO,Xiao-yan ZHANG,Qing-wei GONG,Li MA,Wen-jia LI,Xiao-feng CHEN. Expression and Characterization of Recombinant GLP-1-IgG4-Fc Fusion Protein[J]. China Biotechnology, 2018, 38(7): 58-66.
[4] QIN Rui-ping, LI Ling-xia, MA Xiao-ling, XI Ou-yan, ZHAO Ting, QIU Ling-ling, LI Jiang-wei. Inhibition of Osteoporosis in Ovariectomized Rats Using Follicle-stimulating Hormone Receptor Specific Polyclonal Antibody[J]. China Biotechnology, 2017, 37(6): 9-16.
[5] LIU Yan-Xia, FAN Zhen-Chuan. Polyclonal Antibody Preparation and Application of C.reinhardtii LZTFL1 Protein[J]. China Biotechnology, 2017, 37(11): 109-115.
[6] CAO Rong-yue, YU Min-xia, ZHANG Xin-li, LI Man-man, MIAO Zi-tao, JIN Liang. Construction,Expression,Purification of VEGFⅡ/GRP Fusion Protein and the Effects on RM-1 Prostate Tumor in Mice[J]. China Biotechnology, 2016, 36(8): 9-15.
[7] YANG Si-yuan, PAN Jing-mei, WANG Shuo, DENG Kai-xuan, DENG Qiang, HUANG Xin-he, LI Xue-ru. The Preparation of the Streptolysin O Active Recombinant Protein of Streptococcus pyogenes[J]. China Biotechnology, 2016, 36(6): 51-56.
[8] CHEN Hua-xin, WU Jing, ZHAO Jin, JIANG Peng. Expression and Characterization of Fusion Protein of Single-chain Variable Fragment of Alpha Fetoprotein and Allophycocyanin Alpha Subunit[J]. China Biotechnology, 2016, 36(5): 74-80.
[9] CHEN Xiao-feng, HU Pan, LI Yan-song, GUO Xing, ZOU De-ying, LIU Nan-nan, LU Shi-ying, ZHOU Yu, LIU Zeng-shan, LI Zhao-hui, REN Hong-lin. Molecular Cloning, Prokaryotic Expression and Polyclonal Antibody Preparation of Peroxiredoxin 6 (Prdx6) from Mus musculus[J]. China Biotechnology, 2016, 36(3): 11-16.
[10] GAO Xiang-lei, LIN Shu-shan, GONG Qing-wei, PAN Lan, MA Li, FENG Yan, LIN Xiao-que, ZENG Jian, LI Wen-jia, CHEN Xiao-feng, CHEN Ying. Purification and Characterization of Recombinant Human Glucagon-like Peptide-1 Analogue[J]. China Biotechnology, 2016, 36(12): 15-20.
[11] QIAN Jian ying, XU Zheng hong, DOU Wen fang. Study on the Preparation Technology of Injectable Powder of Fusion Protein GGH[J]. China Biotechnology, 2016, 36(11): 48-53.
[12] LIAO He-bin, LIU Ma-feng, CHENG An-chun. The Assessment of RecA Acted as an Internal Reference Protein in R. anatipestifer[J]. China Biotechnology, 2015, 35(6): 26-31.
[13] GONG Long-cai, LUO Zhen-ming, YANG Yan-qing, WANG Zhen-yu, XIANG Jun-jian, WANG Hong. Prokaryotic Expression and Identification of cTnI-linker-TnC Fusion Protein[J]. China Biotechnology, 2015, 35(4): 48-53.
[14] YAN Li, WANG Kang, LI Rui-jian, BAI Yi, BAI Xian-hong, ZHOU Hai-ping. Manufaction of a New High-glycosylated Fusion Protein NESP-Fc[J]. China Biotechnology, 2015, 35(4): 80-85.
[15] AI Jun, JIANG Chao, LIU Min, WANG Xiao-yan, TIAN Hai-shan, LI Xiao-kun. Two Oleosins Flanking the KGF-2 Improve the Expression Level of KGF-2 in Arabidopsis thaliana and Its Activity Analysis[J]. China Biotechnology, 2015, 35(1): 21-26.